Researchers executed a phase 1b study to determine the safety and efficacy of venetoclax combined with a 7+3 chemotherapy regimen in treating acute myeloid leukemia.

Combination therapy of casdatifan and cabozantinib shows promising efficacy and manageable safety in patients with advanced ...